Sophia Abene

1 week ago | contagionlive.com | Sophia Abene

Presented at ASM Microbe 2025, a process improvement project led by Navarathna et al at Central Texas Veterans Health Care System evaluated the impact of incorporating enzyme immunoassays (EIA) into existing PCR-based diagnostic protocols for Clostridioides difficile infection (CDI). The study compared two EIA platforms against PCR results and found that EIAs were less than 30% as sensitive as PCR.

1 week ago | contagionlive.com | Sophia Abene

June 19, 2025Presented at ASM Microbe 2025, a bioinformatics study highlights nine human miRNAs capable of binding and potentially inhibiting both hepatitis C and bovine viral diarrhea viruses. Presented at ASM Microbe 2025, a bioinformatics-driven study has identified nine human microRNAs (miRNAs) with strong complementary binding to both hepatitis C virus (HCV) and bovine viral diarrhea virus (BVDV), supporting their potential use as targeted antiviral therapeutics.

1 week ago | contagionlive.com | Sophia Abene |Jared Baeten

Gilead Sciences, Inc announced today that the US Food and Drug Administration (FDA) has granted approval for lenacapavir, the company’s first-in-class, long-acting HIV-1 capsid inhibitor, for use as a twice-yearly pre-exposure prophylaxis (PrEP) to prevent HIV infection.

1 week ago | contagionlive.com | Sophia Abene

A recent survey conducted by ValuePenguin involving over 2,000 US adults highlights a significant degree of vaccine skepticism in the general population, with implications for infectious disease management and public health efforts. Approximately 30% of respondents expressed doubts aligned with positions promoted by US Health Secretary Robert F Kennedy Jr, coinciding with a current measles outbreak and enduring safety concerns, including vaccine-autism misconceptions.

1 week ago | contagionlive.com | Sophia Abene |Robert C Bransfield

For over 50 years, psychiatrist Robert C Bransfield, MD, has focused on treating patients with some of the most difficult psychiatric conditions, those resistant to conventional therapies. Over time, his clinical work led him to a surprising pattern: many of these patients had a history of infectious disease, particularly Lyme and other tick-borne illnesses. What he found challenges assumptions in both psychiatry and infectious disease.